169 related articles for article (PubMed ID: 21871156)
1. (±)-3,4-methylenedioxymethamphetamine and metabolite disposition in plasma and striatum of wild-type and multidrug resistance protein 1a knock-out mice.
Scheidweiler KB; Ladenheim B; Barnes AJ; Cadet JL; Huestis MA
J Anal Toxicol; 2011 Sep; 35(7):470-80. PubMed ID: 21871156
[TBL] [Abstract][Full Text] [Related]
2. Mice lacking multidrug resistance protein 1a show altered dopaminergic responses to methylenedioxymethamphetamine (MDMA) in striatum.
Scheidweiler KB; Ladenheim B; Cadet JL; Huestis MA
Neurotox Res; 2010 Aug; 18(2):200-9. PubMed ID: 19851718
[TBL] [Abstract][Full Text] [Related]
3. Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults.
Kolbrich EA; Goodwin RS; Gorelick DA; Hayes RJ; Stein EA; Huestis MA
Ther Drug Monit; 2008 Jun; 30(3):320-32. PubMed ID: 18520604
[TBL] [Abstract][Full Text] [Related]
4. 3,4-Methylenedioxymethamphetamine (MDMA) and metabolites disposition in blood and plasma following controlled oral administration.
Hartman RL; Desrosiers NA; Barnes AJ; Yun K; Scheidweiler KB; Kolbrich-Spargo EA; Gorelick DA; Goodwin RS; Huestis MA
Anal Bioanal Chem; 2014 Jan; 406(2):587-99. PubMed ID: 24232751
[TBL] [Abstract][Full Text] [Related]
5. Analysis of MDMA and its metabolites in urine and plasma following a neurotoxic dose of MDMA.
Valtier S; Phelix CF; Cody JT
J Anal Toxicol; 2007 Apr; 31(3):138-43. PubMed ID: 17579960
[TBL] [Abstract][Full Text] [Related]
6. Studies of (±)-3,4-methylenedioxymethamphetamine (MDMA) metabolism and disposition in rats and mice: relationship to neuroprotection and neurotoxicity profile.
Mueller M; Maldonado-Adrian C; Yuan J; McCann UD; Ricaurte GA
J Pharmacol Exp Ther; 2013 Feb; 344(2):479-88. PubMed ID: 23209329
[TBL] [Abstract][Full Text] [Related]
7. Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA) and its pharmacodynamic consequences in the rat.
Concheiro M; Baumann MH; Scheidweiler KB; Rothman RB; Marrone GF; Huestis MA
Drug Metab Dispos; 2014 Jan; 42(1):119-25. PubMed ID: 24141857
[TBL] [Abstract][Full Text] [Related]
8. Effects of dose and route of administration on pharmacokinetics of (+ or -)-3,4-methylenedioxymethamphetamine in the rat.
Baumann MH; Zolkowska D; Kim I; Scheidweiler KB; Rothman RB; Huestis MA
Drug Metab Dispos; 2009 Nov; 37(11):2163-70. PubMed ID: 19679675
[TBL] [Abstract][Full Text] [Related]
9. Further studies on the role of metabolites in (+/-)-3,4-methylenedioxymethamphetamine-induced serotonergic neurotoxicity.
Mueller M; Yuan J; Felim A; Neudörffer A; Peters FT; Maurer HH; McCann UD; Largeron M; Ricaurte GA
Drug Metab Dispos; 2009 Oct; 37(10):2079-86. PubMed ID: 19628751
[TBL] [Abstract][Full Text] [Related]
10. Contribution of cytochrome P450 2D6 to 3,4-methylenedioxymethamphetamine disposition in humans: use of paroxetine as a metabolic inhibitor probe.
Segura M; Farré M; Pichini S; Peiró AM; Roset PN; Ramírez A; Ortuño J; Pacifici R; Zuccaro P; Segura J; de la Torre R
Clin Pharmacokinet; 2005; 44(6):649-60. PubMed ID: 15910012
[TBL] [Abstract][Full Text] [Related]
11. Urinary MDMA, MDA, HMMA, and HMA excretion following controlled MDMA administration to humans.
Abraham TT; Barnes AJ; Lowe RH; Kolbrich Spargo EA; Milman G; Pirnay SO; Gorelick DA; Goodwin RS; Huestis MA
J Anal Toxicol; 2009 Oct; 33(8):439-46. PubMed ID: 19874650
[TBL] [Abstract][Full Text] [Related]
12. Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") and its major metabolites in squirrel monkeys at plasma concentrations of MDMA that develop after typical psychoactive doses.
Mueller M; Peters FT; Maurer HH; McCann UD; Ricaurte GA
J Pharmacol Exp Ther; 2008 Oct; 327(1):38-44. PubMed ID: 18591215
[TBL] [Abstract][Full Text] [Related]
13. Sprague-Dawley rats display sex-linked differences in the pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolite 3,4-methylenedioxyamphetamine (MDA).
Fonsart J; Menet MC; Debray M; Hirt D; Noble F; Scherrmann JM; Declèves X
Toxicol Appl Pharmacol; 2009 Dec; 241(3):339-47. PubMed ID: 19781562
[TBL] [Abstract][Full Text] [Related]
14. Differential toxic effects of methamphetamine (METH) and methylenedioxymethamphetamine (MDMA) in multidrug-resistant (mdr1a) knockout mice.
Mann H; Ladenheim B; Hirata H; Moran TH; Cadet JL
Brain Res; 1997 Sep; 769(2):340-6. PubMed ID: 9374204
[TBL] [Abstract][Full Text] [Related]
15. Stereoselective urinary MDMA (ecstasy) and metabolites excretion kinetics following controlled MDMA administration to humans.
Schwaninger AE; Meyer MR; Barnes AJ; Kolbrich-Spargo EA; Gorelick DA; Goodwin RS; Huestis MA; Maurer HH
Biochem Pharmacol; 2012 Jan; 83(1):131-8. PubMed ID: 21983032
[TBL] [Abstract][Full Text] [Related]
16. Hair analysis for drug abuse. XV. Disposition of 3, 4-methylenedioxymethamphetamine (MDMA) and its related compounds into rat hair and application to hair analysis for MDMA abuse.
Kikura R; Nakahara Y; Mieczkowski T; Tagliaro F
Forensic Sci Int; 1997 Jan; 84(1-3):165-77. PubMed ID: 9042722
[TBL] [Abstract][Full Text] [Related]
17. Impact of Cytochrome P450 2D6 Function on the Chiral Blood Plasma Pharmacokinetics of 3,4-Methylenedioxymethamphetamine (MDMA) and Its Phase I and II Metabolites in Humans.
Steuer AE; Schmidhauser C; Tingelhoff EH; Schmid Y; Rickli A; Kraemer T; Liechti ME
PLoS One; 2016; 11(3):e0150955. PubMed ID: 26967321
[TBL] [Abstract][Full Text] [Related]
18. Determination of MDMA and its metabolites in blood and urine by gas chromatography-mass spectrometry and analysis of enantiomers by capillary electrophoresis.
Pizarro N; Ortuño J; Farré M; Hernández-López C; Pujadas M; Llebaria A; Joglar J; Roset PN; Mas M; Segura J; Camí J; de la Torre R
J Anal Toxicol; 2002 Apr; 26(3):157-65. PubMed ID: 11991532
[TBL] [Abstract][Full Text] [Related]
19. Two-dimensional gas chromatography/electron-impact mass spectrometry with cryofocusing for simultaneous quantification of MDMA, MDA, HMMA, HMA, and MDEA in human plasma.
Kolbrich EA; Lowe RH; Huestis MA
Clin Chem; 2008 Feb; 54(2):379-87. PubMed ID: 18089653
[TBL] [Abstract][Full Text] [Related]
20. Analysis of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolites in plasma and urine by HPLC-DAD and GC-MS.
Helmlin HJ; Bracher K; Bourquin D; Vonlanthen D; Brenneisen R
J Anal Toxicol; 1996 Oct; 20(6):432-40. PubMed ID: 8889680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
